EUVIMEDEUVIMED entdecken
Crossref

Investigation of PB1‐F2 Protein‐Derived Peptide Effects on Clinical Symptoms and Inflammatory Factors in an Animal Model of Multiple Sclerosis

Seyed Hossein Khatami iD, Saeed Karima, Bahman Jalali Kondori, Mojtaba Sepandi, Zohreh Jangravi

Biotechnology and Applied Biochemistry · 2025

DOI: 10.1002/bab.2790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Seyed Hossein Khatami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental, Peptides, Viral Proteins. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is an autoimmune condition affecting the central nervous system (CNS), resulting in immune‐mediated demyelination and neurodegeneration. The NF‐κB signaling pathway is pivotal in the inflammatory processes that drive MS pathogenesis. Recent research has underscored the therapeutic potential of peptides owing to their low immunogenicity, high specificity, and minimal side effects. PB1‐F2, a protein from the influenza virus, has shown the capacity to modulate inflammation by inhibiting the NF‐κB pathway. Synthetic peptides were designed on the basis of the C‐terminal region of PB1‐F2 and evaluated for their ability to suppress NF‐κB‐mediated inflammatory responses. Among these peptides, RZV8 emerged as the most potent peptide and was selected for further investigation. This study aimed to explore the therapeutic effects of the intraperitoneal administration of RZV8 in experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Following EAE induction in female C57BL/6J mice, the animals were treated with RZV8. Various serum inflammatory mediators, motor functions, myelination, and inflammatory cell infiltration levels were then assessed. Our results demonstrated that RZV8 administration alleviated EAE clinical severity, reducing inflammation, demyelination, and gliosis in EAE mice. We propose that the therapeutic effects of RZV8 are primarily due to its neuroprotective and anti‐inflammatory properties. These results could offer new perspectives for treating neuroinflammatory diseases, such as MS, highlighting RZV8 as a potential therapeutic candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisEncephalomyelitis, Autoimmune, ExperimentalPeptidesViral ProteinsAnimalsMiceFemaleDisease Models, AnimalMice, Inbred C57BLInflammation

Stichwörter der Autor:innen

anti‐inflammatory peptidesdemyelinationexperimental autoimmune encephalomyelitismultiple sclerosis

Substanzen

PeptidesViral ProteinsPB1-F2 protein, Influenza A virus

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
  • Department of Anatomical Sciences, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Health Research Center, Life Style Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Seyed Hossein Khatami

Zitieren

APA

Khatami, S. H., Karima, S., Kondori, B. J., Sepandi, M., & Jangravi, Z. (2025). Investigation of PB1‐F2 Protein‐Derived Peptide Effects on Clinical Symptoms and Inflammatory Factors in an Animal Model of Multiple Sclerosis. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2790

Vancouver

Khatami SH, Karima S, Kondori BJ, Sepandi M, Jangravi Z. Investigation of PB1‐F2 Protein‐Derived Peptide Effects on Clinical Symptoms and Inflammatory Factors in an Animal Model of Multiple Sclerosis. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2790

BibTeX
@article{Khatami2025,
  author = {Khatami, Seyed Hossein and Karima, Saeed and Kondori, Bahman Jalali and Sepandi, Mojtaba and Jangravi, Zohreh},
  title = {Investigation of PB1‐F2 Protein‐Derived Peptide Effects on Clinical Symptoms and Inflammatory Factors in an Animal Model of Multiple Sclerosis},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2025},
  doi = {10.1002/bab.2790}
}
Kostenlos starten →